| Date Filed | Type | Description |
| 08/12/2010 |
4
| Padma-Nathan Harin (CEO) has filed a Form 4 on NURX PHARMACEUTICALS, INC.|
Txns:
| Granted 500,000 options to buy
@ $0.11, valued at
$55k
|
|
| 08/12/2010 |
4
| GERSHICK STEVEN (Chief Financial Officer) has filed a Form 4 on NURX PHARMACEUTICALS, INC.|
Txns:
| Granted 50,000 options to buy
@ $0.11, valued at
$5.5k
|
|
| 04/22/2010 |
4
| Baradaran Sharyar (Director) has filed a Form 4 on NURX PHARMACEUTICALS, INC. |
| 04/22/2010 |
4
| Padma-Nathan Harin (CEO) has filed a Form 4 on NURX PHARMACEUTICALS, INC. |
| 02/24/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/24/2010 |
4
| Baradaran Sharyar (Director) has filed a Form 4 on NURX PHARMACEUTICALS, INC. |
| 02/24/2010 |
4
| Padma-Nathan Harin (CEO) has filed a Form 4 on NURX PHARMACEUTICALS, INC. |
| 02/24/2010 |
4
| LeBel Carl (Director) has filed a Form 4 on NURX PHARMACEUTICALS, INC. |
| 02/24/2010 |
4
| ROSENTHALE MARVIN E (Director) has filed a Form 4 on NURX PHARMACEUTICALS, INC. |
| 02/24/2010 |
3
| LeBel Carl (Director) has filed a Form 3 on NURX PHARMACEUTICALS, INC. |
| 02/24/2010 |
3
| ROSENTHALE MARVIN E (Director) has filed a Form 3 on NURX PHARMACEUTICALS, INC. |
| 02/01/2010 |
4
| GERSHICK STEVEN (CFO) has filed a Form 4 on NURX PHARMACEUTICALS, INC. |
| 11/12/2009 |
4
| Padma-Nathan Harin (CEO) has filed a Form 4 on NURX PHARMACEUTICALS, INC. |
| 11/04/2009 |
4
| Padma-Nathan Harin (Director) has filed a Form 4 on NURX PHARMACEUTICALS, INC. |
| 11/04/2009 |
4
| Baradaran Sharyar (Director) has filed a Form 4 on NURX PHARMACEUTICALS, INC. |
| 06/29/2009 |
3
| Dyva Holding Ltd (10% Owner) has filed a Form 3 on NURX PHARMACEUTICALS, INC. |
| 06/18/2009 |
3
| LEVINE EVAN (Director) has filed a Form 3 on NURX PHARMACEUTICALS, INC. |
| 05/27/2009 |
4
| Hunter World Markets, Inc. (10% Owner) has filed a Form 4 on NURX PHARMACEUTICALS, INC. |
| 03/10/2009 |
4
| GERSHICK STEVEN (CFO) has filed a Form 4 on NURX PHARMACEUTICALS, INC. |
| 02/12/2009 |
4
| GERSHICK STEVEN (CFO) has filed a Form 4 on NURX PHARMACEUTICALS, INC. |